| Model Number |
3889-28 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Swelling (2091)
|
| Date of Event |
03/04/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Information was received from a healthcare professional (hcp) via a manufacturer¿s representative (rep) regarding a patient with an implanted neurostimulator (ins) lead for a trial for gastrointestinal /pelvic floor therapy.It was reported the patient was having an allergic reaction after the procedure and wanted the lead removed.Patient reported rash around the dressing, itching at the site, and reported swelling of her tongue.It was uncertain if the patient was reacting to the dressing.Patient has a history of a tape allergy but no other details provided.Patient has other allergies as well.It was also unsure if the patient was reacting to anesthesia.The rep was informed patient was seen in the office on thursday the 5th for a dressing change and instructed to take benadryl.Patient called the doctor¿s office on friday and was instructed to go to the emergency room.The hcp removed the lead on friday in the or.No further complications were reported or are anticipated.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Additional information was received from a health care professional.It was reported that the cause of the patient's allergic reaction was unclear.No further complications were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Additional information was received from a health care professional.It was reported that the patient¿s allergic reaction did resolve.No further patient complications are anticipated or expected as a result of this event.
|
| |
|
Search Alerts/Recalls
|